GSK Investigational Site

Brighton, Sussex East BN2 5BE

0 studies enrolling now · 6 studies all time

What they study most

Asthma, HIV Infection, Infection, Human Immunodeficiency Virus I, Neoplasms, Head and Neck, Pulmonary Disease, Chronic Obstructive

Studies at this site

• 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old — Completed
• SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma. — Completed
• Dose-Ranging Study Of GSK233705B In Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• GW873140 In Combination With Kaletra In HIV Infected Subjects — Stopped early
• GW873140 In Combination With Combivir In HIV Infected Subjects — Stopped early
• Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery — Completed